PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients

The immunosuppressant azathioprine is used to prevent graft rejection after organ transplantation. To investigate whether azathioprine-associated mutagenesis contributes to the high incidence of skin tumours in organ transplant recipients (OTRs), we analysed PTCH gene mutations in 60 basal cell carc...

Descripción completa

Detalles Bibliográficos
Autores principales: Harwood, C A, Attard, N R, O'Donovan, P, Chambers, P, Perrett, C M, Proby, C M, McGregor, J M, Karran, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570526/
https://www.ncbi.nlm.nih.gov/pubmed/18854826
http://dx.doi.org/10.1038/sj.bjc.6604665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570526/
https://www.ncbi.nlm.nih.gov/pubmed/18854826
http://dx.doi.org/10.1038/sj.bjc.6604665

Ejemplares similares